Atlas Venture Fund XII, L.P. Transaction History

Date Transaction Value Shares Traded Form
Jan 11 2022
BUY
Conversion of derivative security
-
3,859,498
Jan 11 2022
BUY
Open market or private purchase
$7,490,000 $14.0 p/Share
535,000

Also insider at

AVTE
Aerovate Therapeutics, Inc. Healthcare
AVF

Atlas Venture Fund Xii, L.P.

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on VIGL

Follow Vigil Neuroscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIGL shares.

Notify only if

Insider Trading

Get notified when an Vigil Neuroscience, Inc. insider buys or sells VIGL shares.

Notify only if

News

Receive news related to Vigil Neuroscience, Inc.

Track Activities on VIGL